Advances in Radiation Oncology (Jul 2017)

ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II

  • Nicholas G. Zaorsky, MD,
  • Timothy N. Showalter, MD, MPH,
  • Gary A. Ezzell, PhD,
  • Paul L. Nguyen, MD,
  • Dean G. Assimos, MD,
  • Anthony V. D'Amico, MD, PhD,
  • Alexander R. Gottschalk, MD, PhD,
  • Gary S. Gustafson, MD,
  • Sameer R. Keole, MD,
  • Stanley L. Liauw, MD,
  • Shane Lloyd, MD,
  • Patrick W. McLaughlin, MD,
  • Benjamin Movsas, MD,
  • Bradley R. Prestidge, MD, MS,
  • Al V. Taira, MD,
  • Neha Vapiwala, MD,
  • Brian J. Davis, MD, PhD

DOI
https://doi.org/10.1016/j.adro.2017.03.003
Journal volume & issue
Vol. 2, no. 3
pp. 437 – 454

Abstract

Read online

Purpose: To present the most updated American College of Radiology (ACR) Appropriateness Criteria formed by an expert panel on the appropriate delivery of external beam radiation to manage stage T1 and T2 prostate cancer (in the definitive setting and post-prostatectomy) and to provide clinical variants with expert recommendations based on accompanying Appropriateness Criteria for target volumes and treatment planning. Methods and materials: The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a panel of multidisciplinary experts. The guideline development and revision process includes an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In instances in which evidence is lacking or equivocal, expert opinion may supplement available evidence to recommend imaging or treatment. Results: The panel summarizes the most recent and relevant literature on the topic, including organ motion and localization methods, image guidance, and delivery techniques (eg, 3-dimensional conformal intensity modulation). The panel presents 7 clinical variants, including (1) a standard case and cases with (2) a distended rectum, (3) a large-volume prostate, (4) bilateral hip implants, (5) inflammatory bowel disease, (6) prior prostatectomy, and (7) a pannus extending into the radiation field. Each case outlines the appropriate techniques for simulation, treatment planning, image guidance, dose, and fractionation. Numerical rating and commentary is given for each treatment approach in each variant. Conclusions: External beam radiation is a key component of the curative management of T1 and T2 prostate cancer. By combining the most recent medical literature, these Appropriateness Criteria can aid clinicians in determining the appropriate treatment delivery and personalized approaches for individual patients.